| MeSH term | MeSH ID | Detail |
|---|---|---|
| Tuberculosis | D014376 | 20 associated lipids |
| Stomach Ulcer | D013276 | 75 associated lipids |
| Neovascularization, Pathologic | D009389 | 39 associated lipids |
| Lung Diseases | D008171 | 37 associated lipids |
| Inflammation | D007249 | 119 associated lipids |
| Colitis | D003092 | 69 associated lipids |
| Diabetes Mellitus, Type 2 | D003924 | 87 associated lipids |
| Edema | D004487 | 152 associated lipids |
| Osteitis | D010000 | 10 associated lipids |
| Asthma | D001249 | 52 associated lipids |
15-epi-lxa4;15r-lxa4
15-epi-lxa4;15r-lxa4 is a lipid of Fatty Acyls (FA) class. 15-epi-lxa4;15r-lxa4 is associated with abnormalities such as Pneumonia, Septicemia, Cystic Fibrosis, Subarachnoid Hemorrhage and Obesity. The involved functions are known as Protective Agents, Signal Transduction, cytokine biosynthesis, Inflammation and Anabolism. 15-epi-lxa4;15r-lxa4 often locates in Blood, Immune system and Heart tissue. The associated genes with 15-epi-lxa4;15r-lxa4 are IL2 gene, CXCL13 gene and CMKLR1 gene. The related lipids are Steroids. The related experimental models are Knock-out.
Cross Reference
Introduction
To understand associated biological information of 15-epi-lxa4;15r-lxa4, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with 15-epi-lxa4;15r-lxa4?
15-epi-lxa4;15r-lxa4 is suspected in Cystic Fibrosis, Asthma, Chagas Cardiomyopathy, Pneumonia, Septicemia, Subarachnoid Hemorrhage and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 15-epi-lxa4;15r-lxa4
PubChem Associated disorders and diseases
What pathways are associated with 15-epi-lxa4;15r-lxa4
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with 15-epi-lxa4;15r-lxa4?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with 15-epi-lxa4;15r-lxa4?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with 15-epi-lxa4;15r-lxa4?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with 15-epi-lxa4;15r-lxa4?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with 15-epi-lxa4;15r-lxa4?
Knock-out
Knock-out are used in the study 'Aspirin-triggered 15-epi-lipoxin A4 regulates neutrophil-platelet aggregation and attenuates acute lung injury in mice.' (Ortiz-Muñoz G et al., 2014).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with 15-epi-lxa4;15r-lxa4
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Wu Y et al. | Aspirin-triggered lipoxin Aâ‚„ attenuates lipopolysaccharide-induced intracellular ROS in BV2 microglia cells by inhibiting the function of NADPH oxidase. | 2012 | Neurochem. Res. | pmid:22552474 |
| Scully M et al. | Protective role of cyclooxygenase (COX)-2 in experimental lung injury: evidence of a lipoxin A4-mediated effect. | 2012 | J. Surg. Res. | pmid:21944479 |
| Krönke G et al. | The 12/15-lipoxygenase pathway counteracts fibroblast activation and experimental fibrosis. | 2012 | Ann. Rheum. Dis. | pmid:22267335 |
| Xu Z et al. | Lipoxin A4 inhibits the development of endometriosis in mice: the role of anti-inflammation and anti-angiogenesis. | 2012 | Am. J. Reprod. Immunol. | pmid:22229383 |
| Chinthamani S et al. | Lipoxin A4 inhibits immune cell binding to salivary epithelium and vascular endothelium. | 2012 | Am. J. Physiol., Cell Physiol. | pmid:22205391 |
| Das UN | Is lipoxins A₄ a better alternative to anti-VEGF and anti-TNF-α antibody to prevent and treat age-related macular degeneration, diabetic macular edema and retinopathy? | 2012 | Med. Sci. Monit. | pmid:22207123 |
| Bozinovski S et al. | Serum amyloid A opposes lipoxin Aâ‚„ to mediate glucocorticoid refractory lung inflammation in chronic obstructive pulmonary disease. | 2012 | Proc. Natl. Acad. Sci. U.S.A. | pmid:22215599 |
| Vong L et al. | Up-regulation of Annexin-A1 and lipoxin A(4) in individuals with ulcerative colitis may promote mucosal homeostasis. | 2012 | PLoS ONE | pmid:22723974 |
| Zhou CH et al. | [Protective effects and possible mechanism of lipoxin A(4) analogue in rats with acute pancreatitis]. | 2012 | Zhonghua Yi Xue Za Zhi | pmid:22781577 |
| Gilbert NC et al. | Conversion of human 5-lipoxygenase to a 15-lipoxygenase by a point mutation to mimic phosphorylation at Serine-663. | 2012 | FASEB J. | pmid:22516296 |
| Gutierrez AD et al. | The effect of pioglitazone treatment on 15-epi-lipoxin A4 levels in patients with type 2 diabetes. | 2012 | Atherosclerosis | pmid:22687642 |
| Börgeson E et al. | Lipoxin A4 attenuates adipose inflammation. | 2012 | FASEB J. | pmid:22700871 |
| Esper L et al. | Role of SOCS2 in modulating heart damage and function in a murine model of acute Chagas disease. | 2012 | Am. J. Pathol. | pmid:22658486 |
| Verrière V et al. | Lipoxin A4 stimulates calcium-activated chloride currents and increases airway surface liquid height in normal and cystic fibrosis airway epithelia. | 2012 | PLoS ONE | pmid:22662206 |
| Jin H et al. | Lipoxin A4 analog attenuates morphine antinociceptive tolerance, withdrawal-induced hyperalgesia, and glial reaction and cytokine expression in the spinal cord of rat. | 2012 | Neuroscience | pmid:22366510 |
| Gras D et al. | An ex vivo model of severe asthma using reconstituted human bronchial epithelium. | 2012 | J. Allergy Clin. Immunol. | pmid:22409990 |
| Kakazu A et al. | Lipoxin Aâ‚„ inhibits platelet-activating factor inflammatory response and stimulates corneal wound healing of injuries that compromise the stroma. | 2012 | Exp. Eye Res. | pmid:22828048 |
| Mumm JP | Single-molecule microscopy of Cre recombination. | 2012 | Proc. Natl. Acad. Sci. U.S.A. | pmid:23204438 |
| Pertwee RG | Lipoxin A4 is an allosteric endocannabinoid that strengthens anandamide-induced CB1 receptor activation. | 2012 | Proc. Natl. Acad. Sci. U.S.A. | pmid:23204441 |
| Pamplona FA et al. | Anti-inflammatory lipoxin A4 is an endogenous allosteric enhancer of CB1 cannabinoid receptor. | 2012 | Proc. Natl. Acad. Sci. U.S.A. | pmid:23150578 |
| Sun T et al. | LipoxinA(4) induced antinociception and decreased expression of NF-κB and pro-inflammatory cytokines after chronic dorsal root ganglia compression in rats. | 2012 | Eur J Pain | pmid:21658981 |
| Dakin SG et al. | Macrophage sub-populations and the lipoxin A4 receptor implicate active inflammation during equine tendon repair. | 2012 | PLoS ONE | pmid:22384219 |
| Tsai WH et al. | Role of lipoxin A4 in the cell-to-cell interaction between all-trans retinoic acid-treated acute promyelocytic leukemic cells and alveolar macrophages. | 2012 | J. Cell. Physiol. | pmid:21567401 |
| Zimmerman JJ | Exhaled breath condensate: a breathalyzer for lung inflammation. | 2012 | Pediatr Crit Care Med | pmid:22391827 |
| Martin N et al. | Primary human airway epithelial cell-dependent inhibition of human lung mast cell degranulation. | 2012 | PLoS ONE | pmid:22970103 |
| Wu L et al. | Lipoxin A4 inhibits 5-lipoxygenase translocation and leukotrienes biosynthesis to exert a neuroprotective effect in cerebral ischemia/reperfusion injury. | 2012 | J. Mol. Neurosci. | pmid:22661361 |
| Hasan RA et al. | Lipoxin A(4) and 8-isoprostane in the exhaled breath condensate of children hospitalized for status asthmaticus. | 2012 | Pediatr Crit Care Med | pmid:21666533 |
| Balode L et al. | Lipoxygenase-derived arachidonic acid metabolites in chronic obstructive pulmonary disease. | 2012 | Medicina (Kaunas) | pmid:22885362 |
| Jones CN et al. | Microfluidic chambers for monitoring leukocyte trafficking and humanized nano-proresolving medicines interactions. | 2012 | Proc. Natl. Acad. Sci. U.S.A. | pmid:23185003 |
| Su X et al. | Dysfunction of inflammation-resolving pathways is associated with exaggerated postoperative cognitive decline in a rat model of the metabolic syndrome. | 2012 | Mol. Med. | pmid:23296426 |
| Bitto A et al. | Flavocoxid, a dual inhibitor of COX-2 and 5-LOX of natural origin, attenuates the inflammatory response and protects mice from sepsis. | 2012 | Crit Care | pmid:22356547 |
| Dakin SG et al. | Inflamm-aging and arachadonic acid metabolite differences with stage of tendon disease. | 2012 | PLoS ONE | pmid:23155437 |
| Rozsasi A et al. | Cyclooxygenase 2 and lipoxin Aâ‚„ in nasal polyps in cystic fibrosis. | 2011 Nov-Dec | Am J Rhinol Allergy | pmid:22185734 |
| Levy BD et al. | The endogenous pro-resolving mediators lipoxin A4 and resolvin E1 preserve organ function in allograft rejection. | 2011 Jan-Feb | Prostaglandins Leukot. Essent. Fatty Acids | pmid:20869861 |
| Yamaguchi H et al. | Urinary concentrations of 15-epimer of lipoxin A(4) are lower in patients with aspirin-intolerant compared with aspirin-tolerant asthma. | 2011 | Clin. Exp. Allergy | pmid:22093074 |
| Börgeson E et al. | Lipoxin A₄ and benzo-lipoxin A₄ attenuate experimental renal fibrosis. | 2011 | FASEB J. | pmid:21628447 |
| Walker J et al. | Lipoxin a4 increases survival by decreasing systemic inflammation and bacterial load in sepsis. | 2011 | Shock | pmid:21701419 |
| Hao H et al. | Lipoxin A4 and its analog suppress hepatocellular carcinoma via remodeling tumor microenvironment. | 2011 | Cancer Lett. | pmid:21683517 |
| Ni CM et al. | Serum levels of lipoxin A(4) do not predict the development of subsequent asthma among young children with acute bronchiolitis. | 2011 | J Asthma | pmid:21671842 |
| Brancaleone V et al. | Evidence for an anti-inflammatory loop centered on polymorphonuclear leukocyte formyl peptide receptor 2/lipoxin A4 receptor and operative in the inflamed microvasculature. | 2011 | J. Immunol. | pmid:21398608 |
| Das UN | Lipoxin A4 may function as an endogenous anti-arrhythmic molecule. | 2011 | Med. Hypotheses | pmid:20833483 |
| Maldonado-Pérez D et al. | A role for lipoxin A4 as anti-inflammatory and proresolution mediator in human parturition. | 2011 | FASEB J. | pmid:20959513 |
| Zhou M et al. | The protective effects of Lipoxin A4 during the early phase of severe acute pancreatitis in rats. | 2011 | Scand. J. Gastroenterol. | pmid:20950211 |
| Khau T et al. | Annexin-1 signals mitogen-stimulated breast tumor cell proliferation by activation of the formyl peptide receptors (FPRs) 1 and 2. | 2011 | FASEB J. | pmid:20930115 |
| Börgeson E et al. | Lipoxin A₄ inhibits porphyromonas gingivalis-induced aggregation and reactive oxygen species production by modulating neutrophil-platelet interaction and CD11b expression. | 2011 | Infect. Immun. | pmid:21263017 |
| Kenchegowda S et al. | EGF stimulates lipoxin A4 synthesis and modulates repair in corneal epithelial cells through ERK and p38 activation. | 2011 | Invest. Ophthalmol. Vis. Sci. | pmid:21220563 |
| Forsman H et al. | What formyl peptide receptors, if any, are triggered by compound 43 and lipoxin A4? | 2011 | Scand. J. Immunol. | pmid:21535079 |
| Norling LV et al. | Cutting edge: Humanized nano-proresolving medicines mimic inflammation-resolution and enhance wound healing. | 2011 | J. Immunol. | pmid:21460209 |
| Russell R et al. | Lipoxin A4 is a novel estrogen receptor modulator. | 2011 | FASEB J. | pmid:21885654 |
| Basselin M et al. | Anti-inflammatory effects of chronic aspirin on brain arachidonic acid metabolites. | 2011 | Neurochem. Res. | pmid:20981485 |